Lineage Cell Therapeutics Inc (LCTX) — Long-term Investment Intensity
Lineage Cell Therapeutics Inc (LCTX) has a Long-term Investment Intensity of 39.2% as of June 2019. Long-term investments of $59.40 Million represent 39.2% of total assets of $151.69 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Lineage Cell Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Lineage Cell Therapeutics Inc Long-term Investment Intensity (2015–2018)
This chart shows how Lineage Cell Therapeutics Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of June 2019, the intensity stands at 39.2%, reflecting long-term investments of $59.40 Million against total assets of $151.69 Million USD. Explore Lineage Cell Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Lineage Cell Therapeutics Inc (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Lineage Cell Therapeutics Inc from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Lineage Cell Therapeutics Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 54.9% | $55.84 Million | $101.66 Million | ▼ -12.7 pp |
| 2017 | 67.6% | $117.17 Million | $173.24 Million | ▼ -2.5 pp |
| 2016 | 70.2% | $100.04 Million | $142.57 Million | ▲ +65.2 pp |
| 2015 | 4.9% | $4.67 Million | $94.66 Million | — |